Figure 5 from Development and Validation of a Multimodal–Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer

Authors:
Open Access
Publisher website
Google Scholar
Abstract
Kaplan–Meier analysis of DR comparing patients treated with ELT vs. placebo in the NSABP B-42 translational cohort. A, All patients. B, Low-risk group. C, High-risk group. High- and low-risk groups are defined by the M3T model.